X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/02/29/2837979/23024/en/Intercept-Announces-FDA-Acceptance-of-Supplemental-New-Drug-Application-for-Ocaliva-obeticholic-acid-for-the-Treatment-of-PBC.html
https://www.globenewswire.com//news-release/2023/11/13/2779021/23024/en/Intercept-Announces-New-Phase-2-Data-Showing-Significant-Impact-of-OCA-Bezafibrate-Combination-on-Normalization-of-Multiple-Key-Biomarkers-of-PBC-Induced-Liver-Damage-at-AASLD-The-.html
https://www.globenewswire.com//news-release/2023/11/10/2778265/23024/en/Intercept-Announces-New-Findings-from-Long-term-Extension-of-Landmark-POISE-Trial-in-PBC-Showing-Importance-of-Biomarkers-Beyond-ALP-at-AASLD-The-Liver-Meeting-2023.html
https://www.globenewswire.com//news-release/2023/11/08/2776377/23024/en/Alfasigma-completes-acquisition-of-Intercept-Pharmaceuticals-Inc.html
https://www.fiercepharma.com/pharma/after-two-fda-rejections-and-restructuring-plan-intercept-agrees-alfasigma-buyout
https://www.globenewswire.com//news-release/2023/09/05/2737373/23024/en/Intercept-Pharmaceuticals-to-Conduct-Fireside-Chats-and-One-on-One-Meetings-at-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2023/08/02/2716673/23024/en/Intercept-Pharmaceuticals-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Business-Updates.html
https://www.globenewswire.com/news-release/2023/07/26/2711267/23024/en/Intercept-to-Announce-Second-Quarter-2023-Financial-Results-on-August-2-2023.html
Market Place
Share 
